13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-05-19 Event 2025-05-16 SEC 0000902664-25-002479 →

Matrix Capital Management Company, LP Aura Biosciences, Inc. AURA

Stake: 11.17% Shares: 6,922,870 CUSIP: 05153U107 Class: Common Stock, par value $0.00001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 8.86
2,615,841 shares short · +4.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $298K
Point72 Asset Mgmt

Other Filings by Matrix Capital Management Company, LP

FiledFormIssuerStakeShares
2026-01-02 SCHEDULE Zentalis Pharmaceuticals, Inc. ZNTL view →
2023-06-20 SC Zentalis Pharmaceuticals, Inc. ZNTL view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →